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88 i -3  Role of Acute Phase Reactants and Infection as 
Predictors for Major Adverse Clinical Events and 
Angina Pectoris After Percutaneous Coronary 
Intervention 
Braim M. Rahel, Rob J. Diepersloot, Bartelt M. de Jongh, Frank Visseren, Johannes C. 
Kolder, Maarten-Jan Suttorp, Thijs W. Plokker, Heart Lung Center Utrecht, location: SL 
Antonius Hospital, Nieuwegein, The Netherlands. 
Background: Inflammation may play an important role in the development of restenosis 
after percutaneous coronary intervention (PCI). Involvement of previous infection with 
Cytomegalovirus (CMV) and Chlamydia pneumoniae has been postulated. We investi- 
gated the value of acuto-phasa reactants and infection with CMV and Chlamydia pneu- 
moniae in predicting major adverse clinical events (MACE) and angina pectoris (AP) 
after PCI. 
Methods: A total of 600 patients were enrolled (mean age 61.6±10.5 yr, 69.9% male, 
64.2% stented). At baseline CMV-IgG, Chlamydia IgG, and IgA were measured using 
ELISA methods. Also the pro-inflammatory parameters C-raactive protein (CRP), IL-6 
and Lipoprotein(a) were measured. All patients were followed for 8 months. Cardiac 
death, target lesion revascularization (PCI, bypass surgery) and myocardial infarction 
were recorded as MACE. 
Results: In Chlamydia pneumoniae IgA seropositive patients the incidence of MACE was 
12.4% versus 6.9% in seronegative patients (p=0.028). Lipoprotein(a) and CRP levels 
were significantly higher in patients with MACE (280 mg/L versus 192 mg/L, p=0.034 
respectively 4800 mg/L versus 7230 mg/L, p=0,045). Chlamydia pneumoniae IgG, CMV- 
IgG, and IL-6 showed no statistically significant difference. 
CRP levels were also higher in patients with repeat AP (5165 mg/L versus 4071 rag/L, 
p=0.026). Chlamydia and CMV seropositivity, IL-6 and Lipoprotoin(a) were no predictors 
of repeat AP. Correction for stenting and age did not influence the outcome of the various 
parameters. 
Conclusion: The present study indicates that Chlamydia pneumoniae IgA seropositivity 
predicts MACE after PCI. Patients with MACE also showed higher levels of Lipopro- 
toin(a) and CRP suggesting that these acute-phase reactants are correlated with clinical 
events after PCL CRP levels are also correlated with repeat AP after PCI. 
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881-4 No Impact of Statin Treatment on Integrin Expression on 
Leucocytes in Patients With Stable Coronary Artery 
Disease 
Joero Friedrich, Karl M Siegler, Chdstoph Anders, Rahime G~k, B&rbel Klein, Rail 
Winkler, Stefan Weise, Adane Kunkler, Gunnar Taubert, Jcohen Senges, Herzentrum 
Ludwigshafen, 67063 Ludwigshafen, Germany, Institut for H~matologie und 
Transfusionsmedizin, 67063 Ludwlgshafen, Germany. 
Background: activated leucocytes are discussed to be involved in progression of core- 
nary artery disease (CAD). Studies have shown that statin treatment reduces CAD pro- 
gression and the number of acute coronary events. 
Objective: aim of this study was to compare leucocyte expression of the integdns CD11b 
and CD18 and the adhesion molecule CD31, all involved in transepithelial migration of 
monocytes and neutrophils, in consecutive patients with or without statin treatment. 
Methods: 1876 participants of the LURIC (Ludwigshafen Risk and Cardiovascular 
health) study, an ongoing prospective study of environmental and genetic risk factors in 
cardiovascular disease in patients with angiographically documented coronary status, 
were analysed. All patients had coronary stenosis of at least 20% in one vessel, unstable 
and patients with acute ST- or Non-ST infarction < 2 weeks were excluded. Flowcytome- 
try was performed to determine expression of CDllb, CD18 and CD31 on monocytes 
(M) and neutrophils (N). 
Results: Given as mean fluorescence intensity (MFI)/Median values 
No Statins Statins P- value 
CD11 b (M) 6.0 5.9 n.s. 
CD18 (M) 8.5 9.3 0.02 
CD31 (M) 20.9 22.4 <0.001 
CD11b (N) 4.2 4,0 n.s. 
CD18 (N) 3.7 4.0 0.04 
CD3t (N) 5.8 6.2 0.03 
Data were adjusted for age, gender, smoking, hypertension, diabetes, cholesterol, C- 
reactive protein 
Conclusions: 1) In the patients studied a slightly but significantly higher expression of 
the integrin CD18 and of CD31 was observed in the group of patients treated with statins 
2) The antiinflammatory effect of statins in CAD was not related to suppresion of CD11b, 
CD18 or CD31 expression on monocytes and neutrophils. 
273A 
9:30 a.m. 
881-5 Increased C-Reactive Protein Levels in Women at 
Increased Cardiovascular Risk Predict One-Year Events 
Only When Associated With Increased Interleukin-6 
Levels 
Giusaoos M. Rosano, Otovio Gebara, Giuseppo Mercuro, Cdstiano Sarais, Francesca 
"Saiu, Josb Antonio F. Ramires, Massimo Fini, San Raffaele Hospital, Rome, Italy, 
INCOR, Sag Paulo, Brazil. 
Elevated CRP levels suggestive of heightened inflammatory state in vascular conditions 
are often associated with elevated Interleukin-6 (IL-6) levels. It has been suggested that 
CRP and IL-6 may be a predictors of unfavorable outcome in postmenopausal women 
(PMW) receiving hormone reptacement therapy. Because of the possible metabolic effect 
of HRT on CRP the relative predictive importance of CRP and IL-6 levels in PMW receiv- 
ing HRT remains to be elucidated. Therefore we studied 346 consecutive PMW (mean 
age 66+9 years) with cardiovascular dsk >20 in 10 years and receiving HRT for at least 
one year, by measuring CRP and IL-6 before, and 3 months and 1 year after initiation of 
HRT. 
Overall HRT increased CRP levels by 76% while decreased IL-6 levels by 8%, During 1 
year follow up 1 patient died (non cardiac), and 4 had a major cardiovascular event. 
PMW with events had elevated CRP levels compared with baseline but within the 
mean+l SD compared to revels obtained in all women after initiation of HRT. IL-6 levels in 
PMW with events were significantly higher in PMW with events than in those without 
events. IL-6 were predictor of future events while elevated CRP levels were associated 
with an unfavorable outcome only when IL-6 levels were also elevated. In a stepwise 
multivariate analysis IL-6 levels were a stronger predictor of outcome than CRP. CRP 
levels were predictors of future events only after removal of IL-6 levels and presence of 
cardiovascular symptoms from the analysis. 
In conclusion CRP levels are increased in PMW receiving HRT. Elevated IL-6 levels may 
identify those PMW at increased one year risk. CRP levels predict events only when they 
are coupled with IL-6 levels. 
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881-6 Endothelial Microparticles Correlate With High-Risk 
Angiographic Lesions in Acute Coronary Syndromes 
Leon BernaI-Mizrachi. C, Fierro, E. McDonough, J. Purow, W. Jy, H. S. Velasquez, J. J. 
Jimenez, L L. Horstman, Y. S. Ahn, E. Marchena, University of Miami, Miami, Florida. 
Background We previously reported high EMP in patients with acute coronary syn- 
dromes (ACS). Here, we investigated the relation between EMP and morphotogy of coro- 
nary lesions. Methods Three cardiologists blinded to EMP levels independently 
reviewed angiograms of 43 pts (14 MI and 20 UA) using Ambrose classification, c~-CD31- 
PE and ~-CD42-FITC were added to platelet-poor plasma from ACD blood and CD31+/ 
CD42- microparticles <1.5 p.m were assayed as EMP by flow cytometry. Mann-Whitney 
rank sum test was used for statistics. Resuft~ Angiographic findings were grouped as 
high dsk va tow dsk. Mean ±SE of EMP per p,L are shown in the table. [Al l  EMP in 
eccentric type II or multiple irregular lesions were 2.5-fold higher than in type I or concen- 
tric lesions in ACS. [A2] Lesions with thrombi had 3-fold higher EMP than those without. 
[B1] Milder stenosis <45% had 3-fotd higher EMP than those with stenosis >45% and 5- 
fold higher EMP than those without stenosis (3135 ±1102; p<0.01). [B2] Among patients 
with type 2 lesions, those with first ACS had 4-fold EMP compared to those with recurrent 
ACS. 
High risk EMP Low risk EMP p Value 
[All  Eccentric type II or 10706±2787 Eccantdc type I or 4248±1339 <0.05 
multiple irregular lesions concentric lesions N=12 
N=23 N=t2 
[A2] ACS with thrombi 17187±5864 AC$ w/o thrombi N=22 4952 ±827 =0.05 
N=9 
[B1] Stenosis, >45% 5834 ±5085 Stanosis >20% <45% N=9 15212±5462 =0.05 
N=21 
[B2] Recurrent ACS & 4425 ±985 First ACS & eccentric 16464±4762 <0.01 
eccentric type II lesion type II lesion N=I 1 
N=12 
Cgnclusloq [A] EMP levels correlate with high risk angiographic lesions. EMP were 
higher in eccentric type It, multiple irregular as well as lesions with thrombi in ACS 
patients. [B] In contrast, EMP were lower in >45% stenosis and recurrent ACS. This sug- 
gest that damage from severe stenosis or recurrent ischemia reduces capacity of endot- 
helium to release EMP. EMP appear to be a useful marker in detecting higher dsk 
angiographic lesions in ACS. 
